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SUMMARY The response patterns of plasma cortisol and plasma free cortisol have been studied in 20 consecutive patients undergoing cardiac surgery involving the use of heart-lung bypass. Sixteen consecutive patients undergoing closed mitral valvotomy have been used as controls. Total plasma cortisol levels fell at the onset of extracorporeal circulation (ECC) and did not rise significantly throughout the period of ECC. The peak cortisol level in the bypass patients occurred at 24 hours postoperatively with elevated levels still present at 48 hours. This pattern was significantly different from the control patients (P < 0.001) who exhibited the typical cortisol stress response pattern. Synthetic ACTH stimulation of the adrenal cortex INCREASED SECRETION OF CORTISOL from the adrenal cortex is one of the basic features of the metabolic response to stress.1' 2 Previous workers have demonstrated that the pattern of the cortisol response is that of a brisk rise from resting levels to a peak, with a subsequent return to normal values around 24 hours after the period of stress. 3 Though this pattern tends to be uniform for all types of trauma, including surgery, the magnitude of the response is considered to reflect the degree of stress involved.'
During major surgical procedures, e.g., thoracotomy and laparotomy, adrenal secretion of cortisol reaches a maximum. Synthetic ACTH stimulation of the adrenal cortex during these operations produces no further rise in cortisol secretion .5 Though open-heart surgical procedures must be classified as major surgery, they differ from situations previously Plasma free cortisol estimations indicate that a rapid and significant rise in % free cortisol occurred at the onset of ECC, but that despite the rise in percentage free, the overall plasma free cortisol concentration (i.e., total plasma cortisol X % free) was significantly lower during ECC in the bypass patients when compared with control (P < 0.01). Twenty-four hours postoperatively these concentrations were significantly higher in the bypass patients (P < 0.001). described in two respects. During operation there is a period of extracorporeal circulation (ECC) when the patient's cardiorespiratory functions are taken over by the heart-lung bypass machine. In addition, conventional techniques employ controlled hemodilution during the period of ECC, reducing the patient's hematocrit to around 25-30%. Thus, patients undergoing cardiac surgery involving the use of heart-lung bypass are subjected to a period of mechanical extracorporeal circulation and simultaneous hemodilution, in addition to the stress of a major surgical procedure.
Despite the possible effects of such a regime on the patient's metabolic responses, there is relatively little information regarding the biochemical changes which occur during the period of ECC. This paucity of information is even more surprising when it is considered that the postoperative period after heart-lung bypass is itself frequently complicated by metabolic disturbances.
In earlier studies, total plasma cortisol levels after ECC were found to be similar to postoperative levels in general surgical patients.6`8 A reduction in total cortisol during ECC was reported by Mittelman and coworkers' and by Carveth CIRCULATION 20 and associates," while other studies in humans10 and in dogs", 12 showed no such reduction. These early studies must, however, be considered preliminary since the techniques of cortisol measurement were still evolving. The introduction of the fluorometric method of Mattingly'3 and the more specific competitive protein-binding method of Murphy and Patteel' has allowed much greater accuracy in cortisol estimation.
More recently, in a study of plasma cortisol and free cortisol levels in patients undergoing heart-lung bypass, Uozomi and associates"' demonstrated that a marked fall in total plasma cortisol levels occurred at the onset of ECC. There was, however, a simultaneous increase in the free cortisol fraction, i.e., the non-protein bound fraction.
The present study was undertaken to investigate the cortisol response in patients undergoing heart-lung bypass in an attempt to confirm Uozomi and associates' preliminary findings,'5 and thereafter, to extend the investigation through the period of ECC into the postoperative phase.
Materials and Methods
A total of 56 consecutive patients admitted for elective cardiac surgical procedures were studied before, during and after operation. In those patients requiring open-heart procedures, conventional normothermic cardiopulmonary bypass was employed using a 2.5 litre isosmolar Dextrose-Ringer prime. Sixteen patients admitted for closed mitral valvotomy, not requiring heart lung bypass, were used as controls. Of the 40 bypass patients, 28 underwent prosthetic valve replacement, ten underwent coronary artery vein bypass grafting, and two underwent closure of simple congenital cardiac defects. The mean age of the patients studied was 38.75 years (range 21-58) and mean weight 63.94 kg (range 52-87).
The anesthetic regimens were standard in both groups of patients. Premedication was with morphine, 10-15 mg, and atropine, 0.6 mg, by intramuscular injection. Thiopentone sodium was used as induction agent and maintenance anesthesia was nitrous oxide, oxygen, and intravenous morphine. The total morphine dosage given throughout the operative procedure was calculated in each case and was found to be < 0.2 mg/kg body weight (± 0.0008 SEM).
Simultaneous blood sampling for total plasma cortisol, plasma free cortisol, and packed cell volume (PCV) estimations was performed. The sampling times varied and will be indicated with each individual experiment. Laboratory techniques were as follows: 1) Total Plasma Cortisolmeasured by the standard fluorometric method of Mattingly"3 using a Lacarte Fluorimeter with filters having an excitation of 470 nm and a fluorescence of 530 nm. Cross-checks by the competitiveprotein-binding method (CPB) were performed on the preoperative sample in each patient studied. Drug interference with the fluorescent analysis was detected by this method in two patients who had received spironolactone pre-operatively. Subsequent analysis in these patients was by CPB alone. None of the patients studied had received synthetic corticosteroids or quinidine in the three months prior to surgery. Quality control (total plasma cortisol) was C.V. = 8.5% (N = 20) between batches and C.V. = 5% (N = 10) within batches.
2) Plasma Free Cortisolmeasured by equilibrium dialysis"6 at I in 7 dilution with 0.9% sodium chloride containing 0.02% ethylmercurithiosalicylate (THIMEROSAL Sigma Chemical Company), 3.5 ml diluted plasma are contained in 8/32 inch Visking dialysis tubing, placed in a 25 ml flask to which is added 10 ml 0.9% sodium chloride containing 1200 d.p.m/ml of titratec cortisol (1,2,6,7' Hcortisol; specific activity = 90 Ci/nmol). The flask is incubated for 16 hours at 37°C. After incubation the fluids inside and outside the dialysis tubing are sampled with a ml Oxford pipette and the 1 ml samples transferred to a scintillation vial containing 10 ml scintillation fluid. The vials are counted to give a counting error less than 2% using a Packard Tricarb scintillation counter. The results are then calculated as follows, the formula based on From the total plasma cortisol and the % free cortisol, the plasma free cortisol concentration may readily be calculated: Plasma free cortisol concentration = Total plasma cortisol X % free cortisol/100.
Results
The Pattern of Total Plasma Cortisol Response to ECC The pattern of change in plasma cortisol in 20 consecutive heart-lung bypass patients and in 16 consecutive mitral valvotomy control patients is seen in figure 1 and table 1. The control patients exhibited the typical cortisol response to surgical stress with the peak level during the operative procedure. The response in the bypass patients was strikingly different in that at the end of the period of bypass total plasma cortisol had not risen substantially above the upper limit of the normal resting range for total plasma cortisol. A delayed rise then occurred to a peak level at 24 hours after operation with elevated levels still present at 48 hours. The difference between the groups at end bypass or late operative and at 24 hours postoperative are statistically highly significant (P < 0.001). In 20 bypass patients with more frequent sampling times, a more detailed picture of the pattern of change in total plasma cortisol is seen ( fig. 2 ). Before the onset of ECC, the typical rise in total plasma cortisol in response to surgical stress does indeed occur. With the onset of ECC, however, a very rapid and substantial fall occurs in -plasma cortisol level. This low level at the onset of cardiopulmonary bypass (mean 23.02 Mg/I00 ml) does not rise significantly throughout the period of bypass (end-bypass sample mean 25.12 MUg/i00 ml).
Correction was then made for the hemodilution effect of the fluid prime employed in the 20 bypass patients. Individual plasma cortisol values were multiplied by the preoperative baseline PCV divided by the PCV at the time of sampling. Packed cell volume-corrected cortisol values are shown in figure 3 . Corrected values fail to demonstrate the steady rise in plasma cortisol which would have occurred had hemodilution alone been the factor responsible for the previously observed fall in cortisol levels at the onset of bypass. Indeed, corrected values suggest a fall in cortisol secretion as bypass proceeds.
Synthetic ACTH Administration during ECC (table 2) Total plasma cortisol levels were measured in six patients who received 0.25 mg tetracosactrin zinc phosphate (Synacthen) midway through the period of heart-lung bypass; six patients undergoing similar open-heart surgical procedures, not receiving Synacthen, were used as controls. In all six open-heart cases receiving Synacthen, a rise in plasma cortisol in excess of 7.25 Mug/100 ml occurred within 60 min of its administration, i.e., a positive Synacthen response. The six open-heart control patients showed the previously described fall in cortisol levels as ECC progressed. The difference between Synacthen and control groups seen in figure 4 is statistically highly significant (P < 0.001). The positive response to synthetic ACTH in the bypass patients also contrasts with the results in six patients undergoing mitral valvotomy in whom administration of Synacthen immediately after the mitral commissurotomy produced no significant rise in cortisol levels, indicating that the initial response was maximal (P < 0.01).
Percentage-free Cortisol Levels during Heart-Lung Bypass (table 3) The results of percentage of free cortisol estimations in 12 patients are seen in figure 5 (heart-lung bypass group (a) ). Sample times are 5 min prior to ECC (pre-ECC), 5 min after onset of ECC (ECC 1), and 5 min before the end of ECC (ECC 2). The individual and mean values are shown. In all 12 patients, at the onset of ECC there occurred a significant rise in the free cortisol percentage in the plasma (P < 0.01). This elevated percentage free cortisol was maintained throughout the period of ECC. In a further experiment, the pattern of change in percentage free cortisol was measured in six patients undergoing heart-lung bypass (bypass group (b) ), in six patients undergoing closed mitral valvotomy (mitral group), and in ten normal adults. The results are shown in figure 6 . As anticipated, there is no significant difference between bypass patients and mitral valvotomy patients before introduction of ECC, since in both groups there is a rise in percentage free cortisol presumably related to the weaker protein binding of cortisol which occurs with increasing cortisol levels."7 There is however no rise in the valvotomy patients corresponding to the substantial additional rise in percentage free cortisol occurring in the bypass group at the onset of ECC. The difference in percentage free cortisol in the bypass patients is statistically significant when compared with the mitral valvotomy patients (P < 0.001).
Plasma Free Cortisol Concentrations during Heart-Lung Bypass
From the total plasma cortisol and percentage free cortisol values in individual patients, the plasma free cortisol concentration was calculated in six bypass and six control patients (table 4) . It can be seen that in the early part of operation there is a similar rise in plasma free concentration in bypass and valvotomy patients. During the period of ECC, however, the marked fall in total plasma cortisol in the bypass patients is only partly compensated by the rise in percentage free, with the result that the plasma free cortisol concentration is significantly lower than corresponding values in the valvotomy patients (P < 0.01). At 24 hours postoperatively, the plasma free cortisol concentration is substantially increased in the bypass group relative to the valvotomy controls (P < 0.001).
Discussion and Conclusions
This study has demonstrated that during heart-lung bypass the cortisol response differs markedly from the typical cortisol response to stress. Furthermore, the altered response seems to be directly associated with the length of the time a patient is on extracorporeal circulation.
We have confirmed the observations of Britt and associates,' Mittelman and associates" and Uozomi and associates15 by showing that total plasma cortisol falls considerably at the onset of ECC. We have also shown that this low cortisol level is maintained throughout the period of ECC, with cortisol levels at the upper limit of the normal resting range, i.e., around 25 ,ug/100 ml. Such low levels contrast markedly with the peak cortisol levels seen in the closed-heart surgery control patients. Previous authors have presumed that this fall in cortisol is the result of the hemodilution effect of the fluid prime employed in the bypass machine.'" Our studies, however, indicate that dilution alone does not adequately explain the persisting low levels throughout the period of ECC. Indeed, PCVcorrected values suggest a progressive reduction in cortisol secretion as bypass proceeds.
The existence of adreno-cortical hypofunction during periods of stress has been postulated,' though there has been little clinical evidence to support this hypothesis. Ex- perimental work has, however, shown that certain agents can cause adreno-cortical suppression, resulting in reduced cortisol secretion. Morphine, which is commonly used during surgical procedures, has recently been shown to cause diminished pituitary output of ACTH, and to abolish the cortisol response to surgical stress."8 However, the dosage of morphine required to suppress pituitary ACTH (4 mg i.v./kg body weight) is far in excess of that used in conventional anesthetic regimes. The quantities of morphine used in our study patients (< 0.2 mg i.v./kg) have been shown to fail to produce any degree of pituitary-adrenal suppression."' Mathews and Saffron19 have reported that extreme degrees of potassium depletion can impair adreno-cortical secretion in the rabbit. These effects are however delayed and represent an extreme situation, not readily comparable with heart-lung bypass, during which electrolyte levels are closely monitored and have been shown by Walker and associates20 to vary even less than in patients undergoing closed cardiac procedures.
It can be argued that the altered circulatory dynamics of extracorporeal circulation could result in altered adrenal blood flow with a possible reduction in adrenal steroid secretion. Leimann2 has shown that interruption of the adrenal blood supply for 1 to 2 hours will cause progressive reduction in the adreno-cortical response to ACTH. This experimental situation, however, is not found during ECC since it has been shown that blood flow through the adrenal gland is increased during heart-lung bypass. 22 In our study the theory of fixed adreno-cortical suppression becomes untenable when the evidence of the Synacthen 4'FREE CORTISOL -.'0 -------'0 tests is considered. We have clearly shown that though cortisol secretion is submaximal during ECC, the adrenal cortex will respond normally to synthetic ACTH (as shown by the rise in plasma cortisol of > 7.5 ,ug/100 ml in each patient studied). This finding contrasts with previous investigations in general surgical patients5 and with our own control patients undergoing closed-heart procedures, in whom administration of synthetic ACTH during operation produced no further rise in plasma cortisol, indicating an already maximal response. Submaximal adreno-cortical secretion in a gland responsive to synthetic ACTH points to a failure of intrinsic ACTH stimulation, either from failure of pituitary secretion or from suppression of circulating ACTH. We have begun further studies, concerned with pituitary function during heart-lung bypass. The preliminary results in six patients indicate a progressive fall in plasma ACTH levels (measured by radioimmunoassay) during the period of ECC. The validity of these initial observations will only become clear as this work continues.
A rise in the percentage free cortisol in the plasma was first demonstrated by Uozomi and associates. 15 We have shown that this rise in percentage free cortisol occurs rapidly and simultaneously with the onset of ECC; this may be the result of hemodilution which has been shown to liberate free steroid from protein binding sites in vitro.'" In the nonstressed individual, plasma cortisol is predominantly bound to cortisol binding globulin (CBG). This binding is of high affinity but of low capacity, so that as the total plasma cortisol levels rise in stress, CBG binding sites are soon fully taken up, and increasing secondary binding to albumin occurs.', 16 Albumin binding of cortisol is weaker than that of Key CBG, and as a result, there is a progressive rise in plasma free cortisol as total cortisol levels rise (e.g., as seen in the early phase of operation in bypass and control groups). It is now generally accepted that it is the free cortisol which is metabolically active, and that the liberation of free cortisol during stress results in the facilitation of endocrine metabolism in general, and of gluconeogenesis in particular.3 It is therefore of considerable interest that despite the rise in the percentage free cortisol at the onset of ECC, plasma free cortisol concentrations are significantly lower during the period of ECC when compared with control valvotomy patients. Thus, not only is total plasma cortisol reduced during ECC, but the metabolically active plasma free cortisol is also reduced. Further work is clearly indicated in order to determine whether this reduced plasma free cortisol concentration may represent relative cortisol inadequacy in the highly stressful period of ECC or whether the difference in levels is metabolically insignificant. In this regard, it is interesting to note recent reports which have claimed that the administration of synthetic corticosteroids during the period of ECC has been beneficial in terms of improved peripheral circulation during ECC23 and a reduction in postoperative mortality .24 In conclusion, we have described the cortisol response during heart-lung bypass and have shown the ways in which both extracorporeal circulation and hemodilution, techniques currently employed in open-heart surgery, modify this response.
